SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3kex'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1M17_A_AQ4A999_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 LEU A 766 THR A 768 GLY A 774 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.84A	1m17A-3kexA: 32.0	1m17A-3kexA: 54.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	THR A 768 GLY A 774 LEU A 777 ASP A 778 ARG A 781 LEU A 822 ASP A 833 PHE A 834	ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) None None None ANP A 1 (-4.7A) MG A1001 ( 3.1A) None	0.56A	1xkkA-3kexA: 36.0	1xkkA-3kexA: 51.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 9	LEU A 696 VAL A 704 LYS A 723 LEU A 755 LEU A 766	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None None	0.40A	1xkkA-3kexA: 36.0	1xkkA-3kexA: 51.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_B_1N1B502_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.47A	2gqgB-3kexA: 28.2	2gqgB-3kexA: 35.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITO_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 LEU A 766 THR A 768 GLY A 774 ASP A 778 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) None ANP A 1 (-4.7A)	0.57A	2itoA-3kexA: 31.7	2itoA-3kexA: 54.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITY_A_IREA2020_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 GLY A 697 VAL A 704 LYS A 723 LEU A 766 THR A 768 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.71A	2ityA-3kexA: 31.8	2ityA-3kexA: 55.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ITZ_A_IREA2021_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 THR A 768 GLY A 774 ASP A 778 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) None ANP A 1 (-4.7A)	0.68A	2itzA-3kexA: 31.8	2itzA-3kexA: 55.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 VAL A 753 THR A 768 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.69A	2zvaA-3kexA: 27.9	2zvaA-3kexA: 32.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_B_FMMB91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	VAL A 704 LEU A 755 THR A 768 GLY A 774 LEU A 822 ASP A 833 PHE A 834	ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A) None	0.53A	3bbtB-3kexA: 32.4	3bbtB-3kexA: 58.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3BBT_D_FMMD91_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	VAL A 704 LYS A 723 LEU A 766 THR A 768 GLY A 774 LEU A 822 ASP A 833 PHE A 834	ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A) None	0.61A	3bbtD-3kexA: 36.0	3bbtD-3kexA: 58.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CE6_D_ADND500_2 (ADENOSYLHOMOCYSTEINA SE)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	4 / 5	LEU A 773 GLN A 828 HIS A 783 LEU A 787	None	0.90A	3ce6D-3kexA: undetectable	3ce6D-3kexA: 20.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_B_NILB600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 9	LEU A 696 VAL A 704 VAL A 753 LEU A 822 VAL A 831	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 (-4.7A) None	0.79A	3cs9B-3kexA: 25.3	3cs9B-3kexA: 35.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 9	LEU A 696 VAL A 704 LYS A 723 VAL A 753 VAL A 831	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None None	1.10A	3cs9C-3kexA: 24.4	3cs9C-3kexA: 35.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3EYG_A_MI1A1_1 (TYROSINE-PROTEIN KINASE)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	9 / 12	LEU A 696 GLY A 699 GLY A 702 VAL A 704 LYS A 723 SER A 775 ASN A 820 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-2.8A) None ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 2.6A) ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.87A	3eygA-3kexA: 28.1	3eygA-3kexA: 30.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 11	LEU A 696 VAL A 704 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.72A	3g0fA-3kexA: 26.3	3g0fA-3kexA: 28.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G0F_B_B49B9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 10	LEU A 696 VAL A 704 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.63A	3g0fB-3kexA: 26.7	3g0fB-3kexA: 28.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_A_1N1A1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.55A	3g5dA-3kexA: 28.5	3g5dA-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G5D_B_1N1B1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	9 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.68A	3g5dB-3kexA: 28.4	3g5dB-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GVU_A_STIA1001_1 (TYROSINE-PROTEIN KINASE ABL2)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.7A) None	0.64A	3gvuA-3kexA: 24.6	3gvuA-3kexA: 35.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K54_A_1N1A1_1 (TYROSINE-PROTEIN KINASE BTK)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.50A	3k54A-3kexA: 27.7	3k54A-3kexA: 28.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_B_STIB1_1 (TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	LEU A 696 VAL A 704 THR A 768 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.64A	3ms9B-3kexA: 27.3	3ms9B-3kexA: 33.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.54A	3octA-3kexA: 27.2	3octA-3kexA: 28.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.73A	3oezA-3kexA: 27.8	3oezA-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PYY_B_STIB4_1 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.7A) None	0.72A	3pyyB-3kexA: 28.0	3pyyB-3kexA: 32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.64A	3qlgA-3kexA: 28.2	3qlgA-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.81A	3qlgA-3kexA: 28.2	3qlgA-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_B_1N1B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	9 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None MG A1001 ( 3.1A)	0.68A	3qlgB-3kexA: 28.5	3qlgB-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_A_1N1A1_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.48A	3sxrA-3kexA: 27.6	3sxrA-3kexA: 31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3SXR_B_1N1B2_1 (CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.46A	3sxrB-3kexA: 27.2	3sxrB-3kexA: 31.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 LEU A 766 GLY A 774 ASP A 778 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.9A) None ANP A 1 (-4.7A)	0.67A	3ug2A-3kexA: 31.7	3ug2A-3kexA: 53.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	4 / 5	ILE A 744 VAL A 753 LEU A 822 ASP A 833	None None ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.58A	3wzdA-3kexA: 27.3	3wzdA-3kexA: 28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 11	LEU A 696 GLY A 697 VAL A 704 TYR A 770 GLY A 774 SER A 775 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) None ANP A 1 (-4.7A)	0.75A	4ckiA-3kexA: 28.9	4ckiA-3kexA: 28.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 THR A 768 GLY A 774 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.53A	4hjoA-3kexA: 36.0	4hjoA-3kexA: 53.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I22_A_IREA9001_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	9 / 12	LEU A 696 GLY A 697 VAL A 704 LYS A 723 LEU A 766 GLY A 774 ASP A 778 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.9A) None ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.75A	4i22A-3kexA: 35.5	4i22A-3kexA: 54.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IFG_A_1E8A601_1 (CALMODULIN-DOMAIN PROTEIN KINASE 1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	GLY A 697 VAL A 704 LYS A 723 LEU A 755 LEU A 766 GLY A 774 LEU A 822	ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None None ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.73A	4ifgA-3kexA: 24.3	4ifgA-3kexA: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LMN_A_EUIA503_1 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 12	LYS A 723 ASN A 820 ASP A 833 PHE A 834 LEU A 839	ANP A 1 (-3.4A) ANP A 1 ( 2.6A) MG A1001 ( 3.1A) None None	0.83A	4lmnA-3kexA: 24.0	4lmnA-3kexA: 24.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MJ8_A_SPMA202_1 (SPERMIDINE N1-ACETYLTRANSFERASE)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 8	GLU A 687 ILE A 722 GLN A 765 ILE A 725 LEU A 758	None	1.47A	4mj8A-3kexA: undetectable	4mj8A-3kexA: 19.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A)	0.67A	4mxoA-3kexA: 28.1	4mxoA-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXO_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.66A	4mxoB-3kexA: 27.7	4mxoB-3kexA: 33.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_A_DB8A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.58A	4mxxA-3kexA: 28.0	4mxxA-3kexA: 32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.55A	4mxxB-3kexA: 27.7	4mxxB-3kexA: 32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 VAL A 753 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.67A	4mxyB-3kexA: 26.5	4mxyB-3kexA: 32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 VAL A 753 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) None ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.67A	4mxzB-3kexA: 26.5	4mxzB-3kexA: 32.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4OTW_A_DB8A1101_1 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	12 / 12	LEU A 696 VAL A 704 CYH A 721 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832 ASP A 833 VAL A 836	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.5A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None MG A1001 ( 3.1A) None	0.49A	4otwA-3kexA: 42.2	4otwA-3kexA: 99.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZV_B_032B801_1 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 12	VAL A 704 LYS A 723 THR A 768 SER A 775 PHE A 834	ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) None None	0.85A	4rzvB-3kexA: 27.5	4rzvB-3kexA: 29.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WKQ_A_IREA1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 LYS A 723 LEU A 766 THR A 768 GLY A 774 ASP A 778 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) None ANP A 1 (-4.7A)	0.61A	4wkqA-3kexA: 32.4	4wkqA-3kexA: 54.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_A_1N1A601_1 (TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.55A	4xeyA-3kexA: 27.2	4xeyA-3kexA: 28.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_B_1N1B601_1 (TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 THR A 768 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.55A	4xeyB-3kexA: 21.4	4xeyB-3kexA: 28.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XEY_B_1N1B601_1 (TYROSINE-PROTEIN KINASE ABL1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 VAL A 704 LYS A 723 VAL A 753 THR A 768 GLY A 774 LEU A 822	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A)	0.38A	4xeyB-3kexA: 21.4	4xeyB-3kexA: 28.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.60A	4xliA-3kexA: 24.8	4xliA-3kexA: 36.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 LYS A 723 VAL A 753 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.4A) None ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.66A	4xliB-3kexA: 28.7	4xliB-3kexA: 36.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5BVW_A_1N1A1009_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	8 / 12	LEU A 696 VAL A 704 LYS A 723 THR A 768 TYR A 770 GLY A 774 LEU A 822 ALA A 832	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) ANP A 1 (-4.3A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) None	0.67A	5bvwA-3kexA: 27.0	5bvwA-3kexA: 30.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D4N_C_ACTC201_0 (NITROGEN REGULATORY PROTEIN P-II)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	4 / 5	VAL A 921 VAL A 882 GLY A 879 PHE A 946	None	1.08A	5d4nA-3kexA: undetectable 5d4nC-3kexA: undetectable	5d4nA-3kexA: 18.75 5d4nC-3kexA: 18.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_B_1N1B501_1 (PROTEIN-TYROSINE KINASE 6)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	LEU A 696 VAL A 704 THR A 768 GLY A 774 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.9A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.73A	5h2uB-3kexA: 33.4	5h2uB-3kexA: 30.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H2U_C_1N1C501_1 (PROTEIN-TYROSINE KINASE 6)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 12	LEU A 696 THR A 768 GLY A 774 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 ( 4.8A) ANP A 1 ( 4.9A) ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.59A	5h2uC-3kexA: 33.2	5h2uC-3kexA: 30.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HES_A_032A401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 12	VAL A 704 THR A 768 TYR A 770 ASP A 778 PHE A 834	ANP A 1 (-3.9A) ANP A 1 ( 4.8A) ANP A 1 (-4.3A) None None	0.70A	5hesA-3kexA: 27.1	5hesA-3kexA: 30.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HES_B_032B401_1 (MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	VAL A 704 LYS A 723 THR A 768 TYR A 770 ASP A 778 PHE A 834	ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.8A) ANP A 1 (-4.3A) None None	0.78A	5hesB-3kexA: 26.6	5hesB-3kexA: 30.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IZJ_F_AZ1F2_1 (CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA 47P-AZ1-DAR-DAR-DAR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	5 / 7	GLY A 697 GLY A 699 PHE A 701 GLY A 702 VAL A 704	ANP A 1 (-3.7A) ANP A 1 (-2.8A) None None ANP A 1 (-3.9A)	0.56A	5izjB-3kexA: 19.4	5izjB-3kexA: 25.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_A_1E8A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	LEU A 696 GLY A 697 VAL A 704 LYS A 723 LEU A 766 LEU A 822 ASP A 833	ANP A 1 (-4.4A) ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.60A	5yu9A-3kexA: 35.4	5yu9A-3kexA: 15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_B_1E8B1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	7 / 12	GLY A 697 VAL A 704 LYS A 723 LEU A 766 ASP A 778 LEU A 822 ASP A 833	ANP A 1 (-3.7A) ANP A 1 (-3.9A) ANP A 1 (-3.4A) None None ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.83A	5yu9B-3kexA: 35.1	5yu9B-3kexA: 15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_C_1E8C1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	VAL A 704 LYS A 723 LEU A 766 GLY A 774 ASP A 778 ASP A 833	ANP A 1 (-3.9A) ANP A 1 (-3.4A) None ANP A 1 ( 4.9A) None MG A1001 ( 3.1A)	0.70A	5yu9C-3kexA: 30.1	5yu9C-3kexA: 15.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YU9_D_1E8D1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3kex	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3 (Homo sapiens)	6 / 12	VAL A 704 LYS A 723 GLY A 774 ASP A 778 LEU A 822 ASP A 833	ANP A 1 (-3.9A) ANP A 1 (-3.4A) ANP A 1 ( 4.9A) None ANP A 1 (-4.7A) MG A1001 ( 3.1A)	0.81A	5yu9D-3kexA: 30.4	5yu9D-3kexA: 15.79

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1M17_A_AQ4A999_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;LEU A 766;THR A 768;GLY A 774;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.84A","1m17A-3kexA:32.0","1m17A-3kexA:54.05"],["1XKK_A_FMMA91_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"THR A 768;GLY A 774;LEU A 777;ASP A 778;ARG A 781;LEU A 822;ASP A 833;PHE A 834","ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);None;None;None;ANP A   1 (-4.7A); MG A1001 ( 3.1A);None","0.56A","1xkkA-3kexA:36.0","1xkkA-3kexA:51.14"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"LEU A 696;VAL A 704;LYS A 723;LEU A 755;LEU A 766","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;None","0.40A","1xkkA-3kexA:36.0","1xkkA-3kexA:51.14"],["2GQG_B_1N1B502_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;VAL A 753;THR A 768;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.47A","2gqgB-3kexA:28.2","2gqgB-3kexA:35.47"],["2ITO_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;LEU A 766;THR A 768;GLY A 774;ASP A 778;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A)","0.57A","2itoA-3kexA:31.7","2itoA-3kexA:54.74"],["2ITY_A_IREA2020_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;GLY A 697;VAL A 704;LYS A 723;LEU A 766;THR A 768;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.71A","2ityA-3kexA:31.8","2ityA-3kexA:55.05"],["2ITZ_A_IREA2021_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;THR A 768;GLY A 774;ASP A 778;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A)","0.68A","2itzA-3kexA:31.8","2itzA-3kexA:55.05"],["2ZVA_A_1N1A513_1","TYROSINE-PROTEIN KINASE LYN","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;VAL A 753;THR A 768;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.69A","2zvaA-3kexA:27.9","2zvaA-3kexA:32.22"],["3BBT_B_FMMB91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"VAL A 704;LEU A 755;THR A 768;GLY A 774;LEU A 822;ASP A 833;PHE A 834","ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A);None","0.53A","3bbtB-3kexA:32.4","3bbtB-3kexA:58.41"],["3BBT_D_FMMD91_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"VAL A 704;LYS A 723;LEU A 766;THR A 768;GLY A 774;LEU A 822;ASP A 833;PHE A 834","ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A);None","0.61A","3bbtD-3kexA:36.0","3bbtD-3kexA:58.41"],["3CE6_D_ADND500_2","ADENOSYLHOMOCYSTEINASE","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",4,"LEU A 773;GLN A 828;HIS A 783;LEU A 787","None","0.90A","3ce6D-3kexA:undetectable","3ce6D-3kexA:20.16"],["3CS9_B_NILB600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"LEU A 696;VAL A 704;VAL A 753;LEU A 822;VAL A 831","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 (-4.7A);None","0.79A","3cs9B-3kexA:25.3","3cs9B-3kexA:35.59"],["3CS9_C_NILC600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;VAL A 831","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;None","1.10A","3cs9C-3kexA:24.4","3cs9C-3kexA:35.59"],["3EYG_A_MI1A1_1","TYROSINE-PROTEIN KINASE","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",9,"LEU A 696;GLY A 699;GLY A 702;VAL A 704;LYS A 723;SER A 775;ASN A 820;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-2.8A);None;ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 2.6A);ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.87A","3eygA-3kexA:28.1","3eygA-3kexA:30.33"],["3G0F_A_B49A9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.72A","3g0fA-3kexA:26.3","3g0fA-3kexA:28.31"],["3G0F_B_B49B9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.63A","3g0fB-3kexA:26.7","3g0fB-3kexA:28.31"],["3G5D_A_1N1A1_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.55A","3g5dA-3kexA:28.5","3g5dA-3kexA:33.03"],["3G5D_B_1N1B1_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",9,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.68A","3g5dB-3kexA:28.4","3g5dB-3kexA:33.03"],["3GVU_A_STIA1001_1","TYROSINE-PROTEIN KINASE ABL2","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;VAL A 753;THR A 768;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.7A);None","0.64A","3gvuA-3kexA:24.6","3gvuA-3kexA:35.92"],["3K54_A_1N1A1_1","TYROSINE-PROTEIN KINASE BTK","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.50A","3k54A-3kexA:27.7","3k54A-3kexA:28.19"],["3MS9_B_STIB1_1","TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;THR A 768;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.64A","3ms9B-3kexA:27.3","3ms9B-3kexA:33.84"],["3OCT_A_1N1A663_1","TYROSINE-PROTEIN KINASE BTK","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.54A","3octA-3kexA:27.2","3octA-3kexA:28.66"],["3OEZ_A_STIA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.73A","3oezA-3kexA:27.8","3oezA-3kexA:33.03"],["3PYY_B_STIB4_1","V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;VAL A 753;THR A 768;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.7A);None","0.72A","3pyyB-3kexA:28.0","3pyyB-3kexA:32.73"],["3QLG_A_1N1A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.64A","3qlgA-3kexA:28.2","3qlgA-3kexA:33.03"],["3QLG_A_1N1A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.81A","3qlgA-3kexA:28.2","3qlgA-3kexA:33.03"],["3QLG_B_1N1B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",9,"LEU A 696;VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None; MG A1001 ( 3.1A)","0.68A","3qlgB-3kexA:28.5","3qlgB-3kexA:33.03"],["3SXR_A_1N1A1_1","CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.48A","3sxrA-3kexA:27.6","3sxrA-3kexA:31.58"],["3SXR_B_1N1B2_1","CYTOPLASMIC TYROSINE-PROTEIN KINASE BMX","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.46A","3sxrB-3kexA:27.2","3sxrB-3kexA:31.58"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;LEU A 766;GLY A 774;ASP A 778;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A)","0.67A","3ug2A-3kexA:31.7","3ug2A-3kexA:53.59"],["3WZD_A_LEVA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",4,"ILE A 744;VAL A 753;LEU A 822;ASP A 833","None;None;ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.58A","3wzdA-3kexA:27.3","3wzdA-3kexA:28.57"],["4CKI_A_ADNA2022_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;GLY A 697;VAL A 704;TYR A 770;GLY A 774;SER A 775;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A)","0.75A","4ckiA-3kexA:28.9","4ckiA-3kexA:28.37"],["4HJO_A_AQ4A1001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;THR A 768;GLY A 774;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.53A","4hjoA-3kexA:36.0","4hjoA-3kexA:53.12"],["4I22_A_IREA9001_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",9,"LEU A 696;GLY A 697;VAL A 704;LYS A 723;LEU A 766;GLY A 774;ASP A 778;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.75A","4i22A-3kexA:35.5","4i22A-3kexA:54.10"],["4IFG_A_1E8A601_1","CALMODULIN-DOMAIN PROTEIN KINASE 1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"GLY A 697;VAL A 704;LYS A 723;LEU A 755;LEU A 766;GLY A 774;LEU A 822","ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;None;ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.73A","4ifgA-3kexA:24.3","4ifgA-3kexA:21.14"],["4LMN_A_EUIA503_1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"LYS A 723;ASN A 820;ASP A 833;PHE A 834;LEU A 839","ANP A   1 (-3.4A);ANP A   1 ( 2.6A); MG A1001 ( 3.1A);None;None","0.83A","4lmnA-3kexA:24.0","4lmnA-3kexA:24.11"],["4MJ8_A_SPMA202_1","SPERMIDINE N1-ACETYLTRANSFERASE","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"GLU A 687;ILE A 722;GLN A 765;ILE A 725;LEU A 758","None","1.47A","4mj8A-3kexA:undetectable","4mj8A-3kexA:19.51"],["4MXO_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A)","0.67A","4mxoA-3kexA:28.1","4mxoA-3kexA:33.03"],["4MXO_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.66A","4mxoB-3kexA:27.7","4mxoB-3kexA:33.03"],["4MXX_A_DB8A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.58A","4mxxA-3kexA:28.0","4mxxA-3kexA:32.73"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.55A","4mxxB-3kexA:27.7","4mxxB-3kexA:32.73"],["4MXY_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;VAL A 753;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.67A","4mxyB-3kexA:26.5","4mxyB-3kexA:32.73"],["4MXZ_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;VAL A 753;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);None;ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.67A","4mxzB-3kexA:26.5","4mxzB-3kexA:32.73"],["4OTW_A_DB8A1101_1","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",12,"LEU A 696;VAL A 704;CYH A 721;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832;ASP A 833;VAL A 836","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.5A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None; MG A1001 ( 3.1A);None","0.49A","4otwA-3kexA:42.2","4otwA-3kexA:99.69"],["4RZV_B_032B801_1","SERINE\/THREONINE-PROTEIN KINASE B-RAF","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"VAL A 704;LYS A 723;THR A 768;SER A 775;PHE A 834","ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);None;None","0.85A","4rzvB-3kexA:27.5","4rzvB-3kexA:29.18"],["4WKQ_A_IREA1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;LYS A 723;LEU A 766;THR A 768;GLY A 774;ASP A 778;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A)","0.61A","4wkqA-3kexA:32.4","4wkqA-3kexA:54.85"],["4XEY_A_1N1A601_1","TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.55A","4xeyA-3kexA:27.2","4xeyA-3kexA:28.18"],["4XEY_B_1N1B601_1","TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;THR A 768;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.55A","4xeyB-3kexA:21.4","4xeyB-3kexA:28.18"],["4XEY_B_1N1B601_1","TYROSINE-PROTEIN KINASE ABL1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;VAL A 704;LYS A 723;VAL A 753;THR A 768;GLY A 774;LEU A 822","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A)","0.38A","4xeyB-3kexA:21.4","4xeyB-3kexA:28.18"],["4XLI_A_1N1A601_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.60A","4xliA-3kexA:24.8","4xliA-3kexA:36.55"],["4XLI_B_1N1B600_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;LYS A 723;VAL A 753;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.66A","4xliB-3kexA:28.7","4xliB-3kexA:36.55"],["5BVW_A_1N1A1009_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",8,"LEU A 696;VAL A 704;LYS A 723;THR A 768;TYR A 770;GLY A 774;LEU A 822;ALA A 832","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);ANP A   1 (-4.3A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A);None","0.67A","5bvwA-3kexA:27.0","5bvwA-3kexA:30.89"],["5D4N_C_ACTC201_0","NITROGEN REGULATORY PROTEIN P-II","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",4,"VAL A 921;VAL A 882;GLY A 879;PHE A 946","None","1.08A","5d4nA-3kexA:undetectable;5d4nC-3kexA:undetectable","5d4nA-3kexA:18.75;5d4nC-3kexA:18.75"],["5H2U_B_1N1B501_1","PROTEIN-TYROSINE KINASE 6","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"LEU A 696;VAL A 704;THR A 768;GLY A 774;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.9A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.73A","5h2uB-3kexA:33.4","5h2uB-3kexA:30.37"],["5H2U_C_1N1C501_1","PROTEIN-TYROSINE KINASE 6","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"LEU A 696;THR A 768;GLY A 774;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 ( 4.8A);ANP A   1 ( 4.9A);ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.59A","5h2uC-3kexA:33.2","5h2uC-3kexA:30.37"],["5HES_A_032A401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"VAL A 704;THR A 768;TYR A 770;ASP A 778;PHE A 834","ANP A   1 (-3.9A);ANP A   1 ( 4.8A);ANP A   1 (-4.3A);None;None","0.70A","5hesA-3kexA:27.1","5hesA-3kexA:30.92"],["5HES_B_032B401_1","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE MLT","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"VAL A 704;LYS A 723;THR A 768;TYR A 770;ASP A 778;PHE A 834","ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.8A);ANP A   1 (-4.3A);None;None","0.78A","5hesB-3kexA:26.6","5hesB-3kexA:30.92"],["5IZJ_F_AZ1F2_1","CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA;47P-AZ1-DAR-DAR-DAR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",5,"GLY A 697;GLY A 699;PHE A 701;GLY A 702;VAL A 704","ANP A   1 (-3.7A);ANP A   1 (-2.8A);None;None;ANP A   1 (-3.9A)","0.56A","5izjB-3kexA:19.4","5izjB-3kexA:25.13"],["5YU9_A_1E8A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"LEU A 696;GLY A 697;VAL A 704;LYS A 723;LEU A 766;LEU A 822;ASP A 833","ANP A   1 (-4.4A);ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.60A","5yu9A-3kexA:35.4","5yu9A-3kexA:15.79"],["5YU9_B_1E8B1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",7,"GLY A 697;VAL A 704;LYS A 723;LEU A 766;ASP A 778;LEU A 822;ASP A 833","ANP A   1 (-3.7A);ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;None;ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.83A","5yu9B-3kexA:35.1","5yu9B-3kexA:15.79"],["5YU9_C_1E8C1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"VAL A 704;LYS A 723;LEU A 766;GLY A 774;ASP A 778;ASP A 833","ANP A   1 (-3.9A);ANP A   1 (-3.4A);None;ANP A   1 ( 4.9A);None; MG A1001 ( 3.1A)","0.70A","5yu9C-3kexA:30.1","5yu9C-3kexA:15.79"],["5YU9_D_1E8D1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","3kex","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","Homo sapiens",6,"VAL A 704;LYS A 723;GLY A 774;ASP A 778;LEU A 822;ASP A 833","ANP A   1 (-3.9A);ANP A   1 (-3.4A);ANP A   1 ( 4.9A);None;ANP A   1 (-4.7A); MG A1001 ( 3.1A)","0.81A","5yu9D-3kexA:30.4","5yu9D-3kexA:15.79"]]